FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3930511000001101: Cefpodoxime 40mg/5ml oral suspension 50 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21727501000001115 Cefpodoxime 40mg/5ml oral suspension 50 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21727601000001116 Cefpodoxime 40mg/5ml oral suspension 50 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefpodoxime 40mg/5ml oral suspension 50 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Is pack of Cefpodoxime 40mg/5mL pediatric suspension false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has active ingredient Cefpodoxime proxetil false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has active ingredient Cefpodoxime false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has VMP Cefpodoxime 40mg/5mL pediatric suspension false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has specific active ingredient Cefpodoxime proxetil true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has VMP Cefpodoxime 40mg/5ml oral suspension false Inferred relationship Existential restriction modifier
Cefpodoxime 40mg/5ml oral suspension 50 ml Has VMP Cefpodoxime 40mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Is a True Cefpodoxime 40mg/5ml oral suspension 50 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start